Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1994

Study Completion Date

July 31, 2004

Conditions
Respiratory Distress Syndrome, AdultLung Diseases
Interventions
PROCEDURE

Low Tidal Volume Ventilation

PROCEDURE

Positive End-Expiratory Pressure

DRUG

Lysofylline

DRUG

Methylprednisolone

DRUG

Ketoconazole

PROCEDURE

Fluid Management

PROCEDURE

Pulmonary Artery Catheter

Trial Locations (21)

15261

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore

22908

University of Virginia, Charlottesville

27157

Wake Forest University, Winston-Salem

27708

Duke University, Durham

37232

Vanderbilt University, Nashville

44195

Cleveland Clinic Foundation, Cleveland

48109

University of Michigan, Ann Arbor

55905

Mayo Foundation, Rochester

60637

University of Chicago, Chicago

70112

Louisiana State University, New Orleans

77030

Baylor College of Medicine, Houston

80262

University of Colorado Health Sciences Center, Denver

84143

Latter Day Saints Hospital, Salt Lake City

94143

University of California, San Francisco

98105

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

01199

Baystate Medical Center, Springfield

78229-3900

University of Texas, San Antonio

V5Z 1M9

University of British Columbia, Vancouver

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000579 - Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) | Biotech Hunter | Biotech Hunter